This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Point-of-care Molecular Diagnostics Market

Point-of-care Molecular Diagnostics is an Innovation in the Healthcare Sector to Detect Patients Infectious Condition Faster. FMI Analyzes More Trends with the United States, China, and 30+ Countries

Point-of-care Molecular Diagnostics Market by Products & Services, Technology, Application, End User, & Region | Forecast 2023 to 2033

Point-of-care Molecular Diagnostics Market Outlook (2023 to 2033)

The point-of-care molecular diagnostics market is estimated to capture a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is predicted at a CAGR of 9.7% during the forecast period.

Point-of-care Molecular Diagnostics Market – Driving Factors

  • The rising prevalence of chronic and infectious diseases increases the demand for point-of-care molecular diagnostics.
  • Healthcare manufacturers are expanding the laboratory sector due to the growing adoption of point-of-care molecular diagnostics.
  • Rising high costs for testing, delays in results, and time-consuming methods are accelerating the demand for point-of-care molecular diagnostics.
  • Increasing diagnostic tests and preventive medicine are boosting the demand for point-of-care molecular diagnostics.
  • Adopting modern techniques and improving knowledge-related molecular mechanisms drive market growth.
  • Growing demand for point-of-care molecular diagnostics for DNA sequencing and multi-gene examination is booming the market growth.
  • Fast and accurate results and rapid detection of diseases are increasing the sales of point-of-care molecular diagnostics.
  • Adopting point-of-care molecular diagnostics to detect gastrointestinal disorders and respiratory and sexually transmitted diseases is propelling the market expansion.
  • Growing patient awareness and adoption in emerging economies are fuelling market opportunities.
  • Advanced development of microfluidics, government initiatives, and point-of-care molecular diagnostics manufacturers are surging market opportunities.
Customize this Report

Let us know your requirement to get
100% FREE customization

Factors Limit the Growth of the Point-of-care Molecular Diagnostics Market    

Lack of awareness about health and healthcare products in developing countries limits market growth. The absence of reimbursement policies and poor penetration of advanced healthcare devices further hinder the market growth in a few regions.

Emerging Growth Opportunities in the Developing Countries

Manufacturers in developing countries such as India, South Korea, and Brazil significantly produce point-of-care molecular diagnostics. Growing patients population, testing products, advanced healthcare infrastructure, and rising infectious diseases are advancing the market opportunities.

Attributes

Details

Market CAGR (2023 to 2033)

9.7%

Market Valuation (2023)

US$ 4.4 billion

Market Valuation (2033)

US$ 11.1 billion

Point-of-care Molecular Diagnostics Market, 2017 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook

According to Future Market Insights, the global point-of-care molecular diagnostics market is predicted at a healthy 9.7% CAGR during the forecast period. Historically, the market registered a CAGR of 10.4%&between 2017 and 2022.

Increased prevalence of infectious diseases, research and development activities, and early detection of infectious diseases are the factors driving the market growth globally. Apart from these factors, increasingly advanced commercialized technology, diagnostic alternatives, and improved therapeutic are growing the demand for point-of-care molecular diagnostics.&

Adopting point-of-care molecular diagnostics to identify gene expression in molecular biology fosters market growth. In the recent period, healthcare physicians have improved the standard of testing with the ability of quick testing, which consequently increases the demand for point-of-care diagnostics. In 2022, according to the American Cancer Society, around 1.9 million new cancer cases were recorded in the United States.

  • Short Term (2023 to 2026):&Increasing chronic and infectious patients and rising high costs of testing accelerating the demand for point-of-care molecular diagnostics.
  • Medium Term (2026 to 2029):&Rising modern technologies, quick results for testing, and improving knowledge-related molecular mechanisms are expanding market growth.
  • Long Term (2029 to 2033):&Government initiatives, research and development activities, growing economies, and patient awareness-related healthcare advancing market opportunities.

The market is estimated to reach US$ 11.1 billion during the forecast period. Historically, the market stood at US$ 3.4 billion from 2017 to 2022.&

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative Analysis of Adjacent Markets

Point-of-care Molecular Diagnostics Market:

Attributes

Point-of-care Molecular Diagnostics Market

CAGR (2023 to 2033)

9.7%

Value (2023)

US$ 4.4 billion

Value (2033)

US$ 11.1 billion

Trends

Adopting modern techniques and improving knowledge-related molecular mechanisms drive market growth.

Opportunities

Rising patient awareness, growing economies, and low-cost point-of-care molecular diagnostics are driving market opportunities.

Clinical Diagnostics Market:

Attributes

Clinical Diagnostics Market

CAGR (2023 to 2033)

6.1%

Value (2023)

US$ 78.51 billion

Value (2033)

US$ 141.93 billion

Trends

Increasing demand for collecting samples, blood test, and other are accelerating the demand for clinical diagnostics.

Opportunities

High investment, rising chronic diseases, and innovations with advanced technology

Infectious Disease Diagnostic Market:

Attributes

Infectious Disease Diagnostic Market

CAGR (2023 to 2033)

6.4%

Value (2023)

US$ 28.07 billion

Value (2033)

US$ 33.81 billion

Trends

Rising laboratory tests, infectious diseases, and skilled technicians

Opportunities

Government initiatives, high-technology products, and urbanization

Top Two Segments  in the Market

Segments

Product and Services

Top Category

Assays & Kits

Historic CAGR

10.2%

Forecast CAGR

10%

Segments

Technology

Top Category

RT-PCR

Historic CAGR

9.6%

Forecast CAGR

9.2%

Which Product & Service Segment Leads the Market?

Based on products & services, assays & kits are leading the global market by capturing a CAGR of 10% during the forecast period. The growing adoption of assays &kits&products by several end-use industries is surging the market growth. The increasing adoption of assays & kits due to quick and accurate testing is further fueling the market expansion.

Growing demand for assays & kits in the laboratory to research drugs, science life, and environment monitoring is propelling market opportunities. Historically, the assays & kits captured a CAGR of 10.2% between 2017 and 2022.

Which Application Contributes a Lucrative Growth in the Market?

Based on application, respiratory diseases are estimated to lead the global market by securing a significant CAGR during the forecast period. Due to surging respiratory diseases, the testing equipment for infectious illnesses is significantly growing, which results in indriving market growth. According to a report by LANCET, in 2019, nearly 17.2 billion cases related to upper respiratory infections were there around the globe. These factors are expanding the global market by increasing sales.&

RT-PCR Category Dominating the Market in the Technology Segment

Based on technology, the RT-PCR category is leading the global market by securing a CAGR of 9.2% during the forecast period. Due to increasing several testing, including COVID-19, proteomics and genomics are rising the adoption of RT-PCR. The demand for RT-PCR is continuously growing due to cost efficiency, high sensitivity, and low time consumption.&

The demand for RT-PCR is increasing for several other infections, such as Ebola, which favours market opportunities. Historically, the RT-PCR secured a CAGR of 9.6% between 2017 and 2022.

Hospitals & ICUs Segment Drives the Point-of-Care Molecular Diagnostics Market?

Based on end users,&the hospitals & ICUs&segment registered a huge revenue by securing a significant share during the forecast period. Soaring diseases, patient population, and advanced technology testing equipment are driving the hospitals & ICUs segment. The increasing adoption of point-of-care molecular testing by healthcare providers to detect accurate diseases in hospitals & ICUs is surging the market opportunities.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Top Countries Data Table Mentioned Below

Countries United States
CAGR (2017 to 2022) 12.2%
CAGR (2023 to 2033) 9.5%
Valuation (2023 to 2033) US$ 3.9 billion
Countries United Kingdom
CAGR (2017 to 2022) 11.2%
CAGR (2023 to 2033) 8.8%
Valuation (2023 to 2033) US$ 467.1 million
Countries China
CAGR (2017 to 2022) 11.8%
CAGR (2023 to 2033) 9.1%
Valuation (2023 to 2033) US$ 796.5 million
Countries Japan
CAGR (2017 to 2022) 10.7%
CAGR (2023 to 2033) 8.2%
Valuation (2023 to 2033) US$ 651 million
Countries South Korea
CAGR (2017 to 2022) 9.3%
CAGR (2023 to 2033) 7.4%
Valuation (2023 to 2033) US$ 383 million

Favorable Government Support Boosts the United States Market

The United States is to capture a significant portion of the global market by securing a CAGR of 9.5% with a valuation of US$ 3.9 billion during the forecast period. Rising research & development activities, innovation of advanced products, presence of key players, and government initiatives are expanding the United States' point-of-care molecular diagnostics market.

The increase of several chronic diseases, novel products, and prominent expansion in the healthcare sector surged the United States market opportunities. In North America, in 2020, the market surged at a valuation of US$ 1.4 billion. Rising early-stage infectious, POC testing and increasing COVID-19 tests in recent years are expanding the market opportunities in the United States. Historically, the United States secured a CAGR of 12.2% between 2017 and 2022.

Why is Demand for Point-of-Care Molecular Diagnostics rising Across the United Kingdom?

The United Kingdom is registering a CAGR of 8.8% with a valuation of US$ 467.8 million during the forecast period. Rising healthcare infrastructure, urbanization, research & development activities, and huge investments by the government are driving market opportunities in the United Kingdom.

Growing demand for point-of-care molecular PCR to detect chronic and infectious diseases fuels the market size. According to Cancer Research United Kingdom, around 375400 new cancer cases were recorded in the United Kingdom between 2016 and 2018. Historically, the United Kingdom captured a CAGR of 11.2% between 2017 and 2022.

Laboratory Testing Services Surge China Market Size?

China is one of the significant contributors to the Asia-Pacific market. China is securing a CAGR of 9.1% with a valuation of US$ 796.5 million during the forecast period. The increasing number of testing laboratories, clinical testing, and large population is expanding the market growth.

Rising cost-effective and advanced testing boosts the demand for point-of-care molecular diagnostics in China. China's point-of-care molecular diagnostics market historically captured a CAGR of 11.8% between 2017 and 2022.

Competitive Landscape

The number of key marketers uplifts the global market by playing a significant role. These players focus on developing innovative products to enhance the healthcare sector. Their new ideas, tactics, and deep market research welcome better products in the global market.

The distribution channels and innovative advanced novel technology products upsurge the market at another height. Apart from it, they adopted a few marketing strategies such as mergers, partnerships, acquisitions, collaborations, and agreements.

Other Prominent Playersin the Market are

  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • BioMérieux S.A.
  • Danaher Corporation
  • Quidel Corporation
  • QIAGEN N.V.
  • Co-Diagnostics, Inc.
  • Biocartis NV (Belgium)
  • Meridian Bioscience, Inc.
  • Thermo Fisher Scientific, Inc.

Recent Developments:

  • In Mar 2020, Abbott Laboratories launched its new point of care for COVID-19 detection.
  •  
  • In July 2021, QuantuMDxintroduced its quick point-of-care PCR system for detecting Q-POC diagnoses.
  •  
  • In 2022, a molecular diagnostics company- Co-Diagnostics, acquired Idaho Molecular.
  •  
  • In Oct 2020, BioMérieux partnered with Africa Medical Supplies Platform to provide high-quality diagnostics solutions for COVID-19.
  •  
  • In Oct 2018, QIAGEN negotiated with STAT-Dx to enhance its portfolio in testing solutions for next-gen PCR systems.

Scope of Report

Attribute

Details

Forecast Period

2023 to 2033

Historical Data Available for

2017 to 2022

Market Analysis

US$ billion for Value

Key Countries Covered

United States, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa,South Africa, and Türkiye

Key Segments Covered

  • Product and Services
  • Technology
  • End User
  • Application
  • Region

Key Companies Profiled

  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • BioMérieux S.A.
  • Danaher Corporation
  • Quidel Corporation
  • QIAGEN N.V.
  • Co-Diagnostics, Inc.
  • Biocartis NV (Belgium)
  • Meridian Bioscience, Inc.
  • Thermo Fisher Scientific, Inc.

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Point-of-care Molecular Diagnostics Market Segmentation by Category

By Products & Services:

  • Assays & Kits
  • Instruments &Analyzers
  • Software & Services

By Technology:

  • RT-PCR
  • INAAT
  • Other Technologies

By Application:

  • Respiratory Diseases
  • Sexually Transmitted Diseases
  • Hospital-acquired Infections
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Other Applications

By End User:

  • Physicians’ Offices
  • Hospitals & ICUs
  • Research Institutes
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

Frequently Asked Questions

The point-of-care molecular diagnostics market is predicted to secure a 9.7% CAGR through 2033.

The hospital sector drives the point-of-care molecular diagnostics market.

The point-of-care molecular diagnostics market is expected to surpass US$ 11.1 billion by 2033.

The point-of-care molecular diagnostics market is anticipated to be US$ 4.4 billion in 2023.

The United States leads the point-of-care molecular diagnostics market during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product & Service

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product & Service, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product & Service, 2023 to 2033

        5.3.1. Assays & kits

        5.3.2. Instruments & Analyzers

        5.3.3. Software & Services

    5.4. Y-o-Y Growth Trend Analysis By Product & Service, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product & Service, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        6.3.1. RT-PCR

        6.3.2. INAAT

        6.3.3. Other Technologies

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033

        7.3.1. Respiratory Diseases

        7.3.2. Sexually Transmitted Diseases

        7.3.3. Hospital-acquired Infections

        7.3.4. Cancer

        7.3.5. Hepatitis

        7.3.6. Gastrointestinal Disorders

        7.3.7. Other Applications

    7.4. Y-o-Y Growth Trend Analysis By Application , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Physicians Offices

        8.3.2. Hospitals & ICUs

        8.3.3. Research Institutes

        8.3.4. Other End Users

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Product & Service

        10.2.3. By Technology

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product & Service

        10.3.3. By Technology

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product & Service

        11.2.3. By Technology

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product & Service

        11.3.3. By Technology

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Product & Service

        12.2.3. By Technology

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product & Service

        12.3.3. By Technology

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. Thailand

            13.2.1.5. Singapore

            13.2.1.6. Australia

            13.2.1.7. Rest of Asia Pacific

        13.2.2. By Product & Service

        13.2.3. By Technology

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product & Service

        13.3.3. By Technology

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of Middle East and Africa

        14.2.2. By Product & Service

        14.2.3. By Technology

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product & Service

        14.3.3. By Technology

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product & Service

            15.1.2.2. By Technology

            15.1.2.3. By Application

            15.1.2.4. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product & Service

            15.2.2.2. By Technology

            15.2.2.3. By Application

            15.2.2.4. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product & Service

            15.3.2.2. By Technology

            15.3.2.3. By Application

            15.3.2.4. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product & Service

            15.4.2.2. By Technology

            15.4.2.3. By Application

            15.4.2.4. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product & Service

            15.5.2.2. By Technology

            15.5.2.3. By Application

            15.5.2.4. By End User

    15.6. United kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product & Service

            15.6.2.2. By Technology

            15.6.2.3. By Application

            15.6.2.4. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product & Service

            15.7.2.2. By Technology

            15.7.2.3. By Application

            15.7.2.4. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product & Service

            15.8.2.2. By Technology

            15.8.2.3. By Application

            15.8.2.4. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product & Service

            15.9.2.2. By Technology

            15.9.2.3. By Application

            15.9.2.4. By End User

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product & Service

            15.10.2.2. By Technology

            15.10.2.3. By Application

            15.10.2.4. By End User

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product & Service

            15.11.2.2. By Technology

            15.11.2.3. By Application

            15.11.2.4. By End User

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product & Service

            15.12.2.2. By Technology

            15.12.2.3. By Application

            15.12.2.4. By End User

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product & Service

            15.13.2.2. By Technology

            15.13.2.3. By Application

            15.13.2.4. By End User

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product & Service

            15.14.2.2. By Technology

            15.14.2.3. By Application

            15.14.2.4. By End User

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product & Service

            15.15.2.2. By Technology

            15.15.2.3. By Application

            15.15.2.4. By End User

    15.16. GCC Countries

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product & Service

            15.16.2.2. By Technology

            15.16.2.3. By Application

            15.16.2.4. By End User

    15.17. South Africa

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product & Service

            15.17.2.2. By Technology

            15.17.2.3. By Application

            15.17.2.4. By End User

    15.18. Israel

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product & Service

            15.18.2.2. By Technology

            15.18.2.3. By Application

            15.18.2.4. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product & Service

        16.3.3. By Technology

        16.3.4. By Application

        16.3.5. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Abbott Laboratories

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. F. Hoffmann-La Roche Ltd.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. bioMérieux S.A.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Danaher Corporation

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Quidel Corporation

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. QIAGEN N.V.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Co-Diagnostics, Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Biocartis NV

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Meridian Bioscience, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Thermo Fisher Scientific

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 5: Global Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 9: North America Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 10: North America Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 13: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 17: Europe Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 18: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 19: Europe Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 20: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 25: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033

Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2017 to 2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Technology, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Global Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 10: Global Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 11: Global Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 12: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 13: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 14: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 15: Global Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 18: Global Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 21: Global Market Attractiveness by Product & Service, 2023 to 2033

Figure 22: Global Market Attractiveness by Technology, 2023 to 2033

Figure 23: Global Market Attractiveness by Application , 2023 to 2033

Figure 24: Global Market Attractiveness by End User, 2023 to 2033

Figure 25: Global Market Attractiveness by Region, 2023 to 2033

Figure 26: North America Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 27: North America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 28: North America Market Value (US$ Million) by Application , 2023 to 2033

Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 37: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 43: North America Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 46: North America Market Attractiveness by Product & Service, 2023 to 2033

Figure 47: North America Market Attractiveness by Technology, 2023 to 2033

Figure 48: North America Market Attractiveness by Application , 2023 to 2033

Figure 49: North America Market Attractiveness by End User, 2023 to 2033

Figure 50: North America Market Attractiveness by Country, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 52: Latin America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 53: Latin America Market Value (US$ Million) by Application , 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 59: Latin America Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Product & Service, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Technology, 2023 to 2033

Figure 73: Latin America Market Attractiveness by Application , 2023 to 2033

Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 76: Europe Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 77: Europe Market Value (US$ Million) by Technology, 2023 to 2033

Figure 78: Europe Market Value (US$ Million) by Application , 2023 to 2033

Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 84: Europe Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 85: Europe Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 87: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 88: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 90: Europe Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 91: Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 96: Europe Market Attractiveness by Product & Service, 2023 to 2033

Figure 97: Europe Market Attractiveness by Technology, 2023 to 2033

Figure 98: Europe Market Attractiveness by Application , 2023 to 2033

Figure 99: Europe Market Attractiveness by End User, 2023 to 2033

Figure 100: Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: Asia Pacific Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 102: Asia Pacific Market Value (US$ Million) by Technology, 2023 to 2033

Figure 103: Asia Pacific Market Value (US$ Million) by Application , 2023 to 2033

Figure 104: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 121: Asia Pacific Market Attractiveness by Product & Service, 2023 to 2033

Figure 122: Asia Pacific Market Attractiveness by Technology, 2023 to 2033

Figure 123: Asia Pacific Market Attractiveness by Application , 2023 to 2033

Figure 124: Asia Pacific Market Attractiveness by End User, 2023 to 2033

Figure 125: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 126: Middle East and Africa Market Value (US$ Million) by Product & Service, 2023 to 2033

Figure 127: Middle East and Africa Market Value (US$ Million) by Technology, 2023 to 2033

Figure 128: Middle East and Africa Market Value (US$ Million) by Application , 2023 to 2033

Figure 129: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033

Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033

Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033

Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033

Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 146: Middle East and Africa Market Attractiveness by Product & Service, 2023 to 2033

Figure 147: Middle East and Africa Market Attractiveness by Technology, 2023 to 2033

Figure 148: Middle East and Africa Market Attractiveness by Application , 2023 to 2033

Figure 149: Middle East and Africa Market Attractiveness by End User, 2023 to 2033

Figure 150: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Point-Of-Care Genetic Testing Market

Published : March 2017

Google translate

Point-of-care Molecular Diagnostics Market